Neuroblastoma is the most common extracranial solid tumor, arising from primitive
sympathetic ganglion cells, in pediatric patients. The unique features of neuroblastoma …

Neuroblastoma is a very diverse pediatric tumor that starts from the neural crest, and it is
responsible over more than 15% of all juvenile cancer deaths. Clinical signs and symptoms …

The clinical course of neuroblastoma is more heterogeneous than any other malignant
disease. Most low-risk patients experience regression after limited or even no …

PURPOSE: Minimally invasive adrenalectomy (MIA) is the criterion standard for removal of
small adrenal tumors in adults. The purpose of this review was to determine the place of MIA …

Purpose To evaluate local control after 21-Gy radiation therapy (RT) to the primary site in
patients with high-risk neuroblastoma. Methods and Materials After receiving dose-intensive …

PURPOSE: To report the early outcomes for children with high-risk neuroblastoma treated
with proton radiotherapy (RT) and to compare the dose distributions for intensity-modulated …

Background: Half the children with high-risk neuroblastoma die with widespread
metastases. Molecular radiotherapy is an attractive systemic treatment for this relatively …

Aims External beam radiotherapy is widely used in various ways in the management of
neuroblastoma. Despite extensive clinical experience, the precise role of radiotherapy in …

Objective Radiotherapy (RT) is an integral part of the interdisciplinary treatment of patients
with high-risk neuroblastoma (NB). With the continuous improvements of outcome, the …

Numerous studies have shown that for optimal survival in localized International
Neuroblastoma Staging System stage 1–3 neuroblastoma, complete tumour resection (CR …